Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Farmers Insurance
Chubb
US Department of Justice
Moodys
Express Scripts
Healthtrust
Federal Trade Commission
Boehringer Ingelheim
Cerilliant

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204426

« Back to Dashboard
NDA 204426 describes TAYTULLA, which is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the TAYTULLA profile page.

The generic ingredient in TAYTULLA is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for NDA: 204426

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 204426

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAYTULLA
ethinyl estradiol; norethindrone acetate
CAPSULE;ORAL 204426 NDA Allergan, Inc. 0023-5862 0023-5862-30 5 CARTON in 1 TRAY (0023-5862-30) > 1 BLISTER PACK in 1 CARTON (0023-5862-28) > 1 KIT in 1 BLISTER PACK
TAYTULLA
ethinyl estradiol; norethindrone acetate
CAPSULE;ORAL 204426 NDA Warner Chilcott (US), LLC 0430-0539 0430-0539-50 5 CARTON in 1 TRAY (0430-0539-50) > 1 BLISTER PACK in 1 CARTON (0430-0539-14) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.02MG;1MG
Approval Date:Apr 19, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Mar 29, 2020Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 204426

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil
TAYTULLA
ethinyl estradiol; norethindrone acetate
CAPSULE;ORAL204426-001Apr 19, 2013► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cipla
US Army
Mallinckrodt
Baxter
Harvard Business School
Healthtrust
Express Scripts
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot